Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Atopic dermatitis: an overview.

Berke R, Singh A, Guralnick M.

Am Fam Physician. 2012 Jul 1;86(1):35-42. Review.

2.

The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.

Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L.

Health Technol Assess. 2005 Jul;9(29):iii, xi-xiii,1-230. Review.

3.

Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.

Breuer K, Werfel T, Kapp A.

Am J Clin Dermatol. 2005;6(2):65-77. Review.

PMID:
15799678
4.
5.

Treatment options for atopic dermatitis.

Buys LM.

Am Fam Physician. 2007 Feb 15;75(4):523-8. Review.

6.

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.

Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.

J Dermatolog Treat. 2005 Aug;16(3):142-8.

PMID:
16096179
7.

[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].

Gliński W, Kruszewski J, Silny W, Kurzawa R, Czarnecka-Operacz M, Baran E, Szepietowski J; Task Force of the National Specialists on Dermatology, Venereology and Allergology.

Pol Merkur Lekarski. 2004;17 Suppl 3:3-15. Review. Polish.

PMID:
15688665
8.

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis.

Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza AM, Giusti F, Lübbe J, Seidenari S, Ring J; European Task Force on Atopic Dermatitis/EADV Eczema Task Force.

J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28. doi: 10.1111/j.1468-3083.2009.03415.x. Epub 2009 Aug 31. Review.

PMID:
19732254
9.

The role of topical calcineurin inhibitors in atopic dermatitis.

Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K; European Working Group on Atopic Dermatitis.

Br J Dermatol. 2004 Dec;151 Suppl 70 Dec 2004:3-27. Review.

PMID:
15548171
10.

Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.

Munzenberger PJ, Montejo JM.

Pharmacotherapy. 2007 Jul;27(7):1020-8. Review.

PMID:
17594208
11.

Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.

Draelos ZD.

Curr Med Res Opin. 2008 Apr;24(4):985-94. doi: 10.1185/030079908X280419 . Epub 2008 Feb 18. Review.

PMID:
18284804
12.

Atopic dermatitis: an overview for the nurse practitioner.

Mack S.

J Am Acad Nurse Pract. 2004 Oct;16(10):451-4. Review.

PMID:
15543922
13.

Treatment of childhood eczema.

Granlund H.

Paediatr Drugs. 2002;4(11):729-35. Review.

PMID:
12390044
14.

Therapy of atopic eczema.

Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM.

GMS Health Technol Assess. 2006 Oct 6;2:Doc19.

15.
16.
17.

Spotlight on topical pimecrolimus in atopic dermatitis.

Wellington K, Jarvis B.

Am J Clin Dermatol. 2002;3(6):435-8. Review.

PMID:
12113651
18.

The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.

Hoeger PH, Lee KH, Jautova J, Wohlrab J, Guettner A, Mizutani G, Hultsch T.

Br J Dermatol. 2009 Feb;160(2):415-22. doi: 10.1111/j.1365-2133.2008.08928.x. Epub 2008 Nov 25. Erratum in: Br J Dermatol. 2009 Jun;160(6):1362.

PMID:
19067708
19.

[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].

de Bruin-Weller MS, Bruijnzeel-Koomen CA.

Ned Tijdschr Geneeskd. 2005 May 14;149(20):1096-100. Review. Dutch.

PMID:
15932135
20.

Atopic dermatitis: a review of diagnosis and treatment.

Correale CE, Walker C, Murphy L, Craig TJ.

Am Fam Physician. 1999 Sep 15;60(4):1191-8, 1209-10. Review.

Supplemental Content

Support Center